Naveed Saleh. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Aniline Compounds/therapeutic useClinical Trials, Phase III as TopicDrug ApprovalDrug Resistance, NeoplasmHumansLeukemia, Myeloid, Acute/drug therapyLeukemia, Myeloid, Acute/geneticsLeukemia, Myeloid, Acute/pathologyMutationNeoplasm Recurrence, Local/drug therapyNeoplasm Recurrence, Local/geneticsNeoplasm Recurrence, Local/pathologyProtein Kinase Inhibitors/therapeutic usePyrazines/therapeutic useSalvage TherapySurvival RateTreatment Outcomefms-Like Tyrosine Kinase 3/genetics
Substances： See more » Aniline CompoundsProtein Kinase InhibitorsPyrazinesgilteritinibFLT3 protein, humanfms-Like Tyrosine Kinase 3
Year: 2019 PMID： 31469903
Source DB: PubMed Journal: Oncology (Williston Park) ISSN： 0890-9091 Impact factor: 2.990